How many clinical trials has Qilu Hospital of Shandong University sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by Qilu Hospital of Shandong University, of which 14 are actively recruiting participants. These trials cover conditions including Cancer of Stomach, Adenocarcinoma, Ascites, Malignant, Carcinoma, Hepatocellular. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Qilu Hospital of Shandong University research focus on?
Qilu Hospital of Shandong University clinical trials span Cancer of Stomach, Adenocarcinoma, Ascites, Malignant, Carcinoma, Hepatocellular, Immunotherapy, Non ST Segment Elevation Acute Coronary Syndrome, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Qilu Hospital of Shandong University clinical trial?
To participate in a Qilu Hospital of Shandong University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Qilu Hospital of Shandong University trials with current recruitment status updated daily.